Metabolic dysfunction-associated steatotic liver disease in primary care: an international Delphi consensus
Gong Feng, 宫守平, Frank Tacke, Luca Valenti et autres
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide, with general practitioners and family doctors (collectively referred to as GPs) playing a key role in its management. However, numerous challenges persist in primary care settings. We aimed …
cn, de, it, sg, jp, gb, Égypte, my, tr, us, ca, au, kr, sa, th, in, dk, Afrique du Sud, id, mx, cu, Kenya, hk, pk, pt, pl, Ouganda, ae, il (code pays fourni par la source)
0 citations
The Lancet Primary Care